Asthma is a chronic disease which shows various symptoms such as coughing, wheezing, chest tightness and breath shortness. Asthma is caused by environmental and genetic factors. The environmental factors include exposure to air pollution, pollen grains and allergens. The pulmonary airway muscles get swollen due to allergens, which cause bronchospasm and airway obstruction. Patients with genetic history of asthma are more prone to developing asthma. Asthma can be controlled by early asthma treatment. The medications include long acting beta-agonists (LABA), corticosteroids, anti-inflammatory agents and leukotriene modifiers. Asthma patients are always at risk of developing with pneumonia and influenza. Asthma mimicking symptoms have been found in a host of diseases in children. Hence, diagnosis and treatment of asthma in children has remained a challenge.
According to the Global Initiative for Asthma (GINA), in 2013, 300 million patients globally were reported to be afflicted with asthma and the number is expected to grow in the coming years.
To Know How COVID-19 Pandemic Will Impact Global Asthma Therapeutics Market | Get a Sample Copy of Report, Click Here: https://www.theinsightpartners.com/sample/TIPRE00004065/
Top Leading companies like
Teva Pharmaceutical Industries Ltd.
F. Hoffmann La-Roche Ltd.
Boehringer Ingelheim GmbH
Sunovion Pharmaceuticals, Inc.
The global asthma therapeutics market is segmented on the basis of product type, drug class and route of administration. Based on products type, the market is segmented as dry powder inhalers, metered dose inhalers, mist inhalers and nebulizer. On the basis of drug class, the global asthma therapeutics market is segmented into anti-inflammatory drugs, bronchodilators and combination therapy. Based on route of administration, the market segmented into oral, inhaled, intravenous and subcutaneous.
Report Introduction, Overview, and In-depth industry analysis
150+ Pages Research Report
Includes List of table & figures
Regional Analysis with Graphical Representation of Size, Share & Trends
Provide Chapter-wise guidance on Request
Facts and Factors research methodology
Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
The Asthma Therapeutics market is segmented on the basis of service type and end user. Based on service type, the market is segmented as retirement communities, group care homes, nursing care facilities, and home health care providers. On the basis of end user, the market is categorized as male nursing care and female nursing care.
The report is a combination of qualitative and quantitative analysis of the Asthma Therapeutics industry. The global market majorly considers five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America (SACM). The report also focuses on the exhaustive PEST analysis and extensive market dynamics during the forecast period.
Reason to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Asthma Therapeutics market.
Highlights key business priorities in order to guide the companies to reform their business strategies and establish themselves in the wide geography.
The key findings and recommendations highlight crucial progressive industry trends in the Asthma Therapeutics market, thereby allowing players to develop effective long term strategies in order to garner their market revenue.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Purchase a copy of the report @ https://www.theinsightpartners.com/buy/TIPRE00004065/
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
Email: [email protected]